Trial Profile
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Benzoyl peroxide/tretinoin (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Bausch Health Companies
- 21 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 08 Sep 2015 New trial record